Home > Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.

Dolan, Kate and Wirtz, Andrea L and Moazen, Babak and Ndeff o-mbah, Martial and Galvani, Alison and Kinner, Stuart A and Courtney, Ryan and McKee, Martin and Amon, Joseph J and Maher, Lisa and Hellard, Margaret and Beyrer, Chris and Altice, Frederick . (2016) Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Elsevier. The Lancet, 388 (10049)

URL: http://www.thelancet.com/series/aids-2016


The prison setting presents not only challenges, but also opportunities, for the prevention and treatment of HIV, viral hepatitis, and tuberculosis. We did a comprehensive literature search of data published between 2005 and 2015 to understand the global epidemiology of HIV, hepatitis C virus (HCV), hepatitis B virus (HBV), and tuberculosis in prisoners. We further modelled the contribution of imprisonment and the potential impact of prevention interventions on HIV transmission in this population. Of the estimated 10·2 million people incarcerated worldwide on any given day in 2014, we estimated that 3·8% have HIV (389 000 living with HIV), 15·1% have HCV (1 546 500), 4·8% have chronic HBV (491 500), and 2·8% have active tuberculosis (286 000). The few studies on incidence suggest that intraprison transmission is generally low, except for large-scale outbreaks. Our model indicates that decreasing the incarceration rate in people who inject drugs and providing opioid agonist therapy could reduce the burden of HIV in this population. The prevalence of HIV, HCV, HBV, and tuberculosis is higher in prison populations than in the general population, mainly because of the criminalisation of drug use and the detention of people who use drugs. The most eff ective way of controlling these infections in prisoners and the broader community is to reduce the incarceration of people who inject drugs.

Item Type:Evidence resource
Drug Type:Alcohol or other drugs in general, Opioid
Intervention Type:AOD disorder harm reduction, Screening
Date:2016
Publisher:Elsevier
Volume:388
Number:10049
Notes:This is the first in a Series of six papers on HIV and related infections in prisoners. The other articles are not open access you can request a copy at drugslibrary@hrb.ie
EndNote:View
Accession Number:HRB (Electronic Only)
Subjects:B Substances > Opioids (opiates)
G Health and disease > Etiology > Disease transmission factor > Needle sharing
G Health and disease > Disorder by cause > Communicable disease > Viral hepatitis
HJ Treatment method > Substance disorder treatment method > Substance replacement method (substitution)
J Health care, prevention and rehabilitation > Health related prevention > Health information and education > Communicable disease control
J Health care, prevention and rehabilitation > Health related prevention > Health information and education > Communicable disease control > HIV prevention
MM-MO Crime and law > Justice system > Correctional system and facility > Prison
T Demographic characteristics > Prison Inmate (prisoner)
VA Geographic area > International aspects

Repository Staff Only: item control page